 |
 |
 |
|
 | |||||
| |||||||||
 | |||||||||
|
|
 |
|
|
Prescription and Over-the-Counter Drug Product List Prescription OTCNOTE: The format for the Monthly Additions/Deletions Drug
Product List changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.6
Cumulative Supplement Legend. ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ABARELIX
INJECTABLE; INTRAMUSCULAR
PLENAXIS
>D> @ PRAECIS 100MG/VIAL N21320 001 Nov 25, 2003 Feb CAHN
>A> @ SPECIALITY EUROPEAN 100MG/VIAL N21320 001 Nov 25, 2003 Feb CAHN
ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
TABLET; ORAL
ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE
>D> AB + MIKART 712.8MG;60MG;32MG N40316 001 Apr 28, 1999 Feb CTEC
>A> AA + 712.8MG;60MG;32MG N40316 001 Apr 28, 1999 Feb CTEC
ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITATRATE
>D> AB WEST WARD 712.8MG;60MG;32MG N40637 001 Sep 22, 2006 Feb CTEC
>A> AA 712.8MG;60MG;32MG N40637 001 Sep 22, 2006 Feb CTEC
ACETAMINOPHEN; HYDROCODONE BITARTRATE
TABLET; ORAL
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
>A> AA INTERPHARM 500MG;10MG N40813 001 Feb 23, 2007 Feb NEWA
ALPRAZOLAM
TABLET, EXTENDED RELEASE; ORAL
ALPRAZOLAM
>A> AB TEVA PHARMS 0.5MG N77979 001 Feb 28, 2007 Feb NEWA
>A> AB 1MG N77979 002 Feb 28, 2007 Feb NEWA
>A> AB 2MG N77979 003 Feb 28, 2007 Feb NEWA
>A> AB 3MG N77979 004 Feb 28, 2007 Feb NEWA
TABLET; ORAL
ALPRAZOLAM
>D> @ CLONMEL HLTHCARE 0.25MG N74174 001 Oct 19, 1993 Feb CAHN
>D> @ 0.5MG N74174 002 Oct 19, 1993 Feb CAHN
>D> @ 1MG N74174 003 Oct 19, 1993 Feb CAHN
>D> @ 2MG N74174 004 Oct 19, 1993 Feb CAHN
>A> @ DAVA INTL INC 0.25MG N74174 001 Oct 19, 1993 Feb CAHN
>A> @ 0.5MG N74174 002 Oct 19, 1993 Feb CAHN
>A> @ 1MG N74174 003 Oct 19, 1993 Feb CAHN
>A> @ 2MG N74174 004 Oct 19, 1993 Feb CAHN
ARIPIPRAZOLE
TABLET, ORALLY DISINTEGRATING; ORAL
ABILIFY
>D> OTSUKA 10MG N21729 002 Jun 07, 2006 Feb CRLD
>A> + 10MG N21729 002 Jun 07, 2006 Feb CRLD
>D> + 30MG N21729 005 Jun 07, 2006 Feb CRLD
>A> 30MG N21729 005 Jun 07, 2006 Feb CRLD
TABLET; ORAL
ABILIFY
>D> + OTSUKA 15MG N21436 002 Nov 15, 2002 Feb CRLD
>A> 15MG N21436 002 Nov 15, 2002 Feb CRLD
>D> + 30MG N21436 004 Nov 15, 2002 Feb CRLD
>A> 30MG N21436 004 Nov 15, 2002 Feb CRLD
BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
OINTMENT; OPHTHALMIC
>D> CORTISPORIN
>D> AT MONARCH PHARMS 400 UNITS/GM;1%;EQ 3.5MG N50416 002 Feb DISC
>A> @ 400 UNITS/GM;1%;EQ 3.5MG N50416 002 Feb DISC
NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE
>D> AT + BAUSCH AND LOMB 400 UNITS/GM;1%;EQ 3.5MG N64068 001 Oct 30, 1995 Feb CTEC
>A> + 400 UNITS/GM;1%;EQ 3.5MG N64068 001 Oct 30, 1995 Feb CTEC
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
OINTMENT; OPHTHALMIC
>D> NEOSPORIN
>D> AT MONARCH PHARMS 400 UNITS/GM;EQ 3.5MG N50417 001 Feb DISC
>A> @ 400 UNITS/GM;EQ 3.5MG N50417 001 Feb DISC
BACITRACIN ZINC; POLYMYXIN B SULFATE
OINTMENT; OPHTHALMIC
>D> POLYSPORIN
>D> AT MONARCH PHARMS 500 UNITS/GM;10,000 UNITS/GM N61229 001 Feb DISC
>A> @ 500 UNITS/GM;10,000 UNITS/GM N61229 001 Feb DISC
BUDESONIDE
POWDER, METERED; INHALATION
>D> BUDESONIDE
>D> ASTRAZENECA 0.08MG/INH N21949 001 Jul 12, 2006 Feb CTNA
>D> + 0.16MG/INH N21949 002 Jul 12, 2006 Feb CTNA
>A> PULMICORT FLEXHALER
>A> ASTRAZENECA 0.08MG/INH N21949 001 Jul 12, 2006 Feb CTNA
>A> + 0.16MG/INH N21949 002 Jul 12, 2006 Feb CTNA
CABERGOLINE
TABLET; ORAL
CABERGOLINE
>A> AB IVAX PHARMS INC 0.5MG N77750 001 Mar 07, 2007 Feb NEWA
CARISOPRODOL
TABLET; ORAL
CARISOPRODOL
>A> AA SUN PHARM INDS LTD 350MG N40755 001 Feb 27, 2007 Feb NEWA
CEFTIZOXIME SODIUM
INJECTABLE; INJECTION
CEFIZOX
>D> ASTELLAS EQ 1GM BASE/VIAL N63294 002 Mar 31, 1994 Feb CRLD
>A> + EQ 1GM BASE/VIAL N63294 002 Mar 31, 1994 Feb CRLD
>D> + EQ 1GM BASE/VIAL N50560 002 Sep 15, 1983 Feb DISC
>A> @ EQ 1GM BASE/VIAL N50560 002 Sep 15, 1983 Feb DISC
CEFTRIAXONE SODIUM
INJECTABLE; IM-IV
CEFTRIAXONE
>A> AP HANFORD GC EQ 1GM BASE/VIAL N65268 001 Feb 28, 2007 Feb NEWA
>A> AP EQ 2GM BASE/VIAL N65268 002 Feb 28, 2007 Feb NEWA
INJECTABLE; INJECTION
CEFTRIAXONE
>A> AP HANFORD GC EQ 10GM BASE/VIAL N65269 001 Feb 28, 2007 Feb NEWA
CHLORAMPHENICOL SODIUM SUCCINATE
INJECTABLE; INJECTION
CHLORAMPHENICOL SODIUM SUCCINATE
>D> AP ABRAXIS PHARM EQ 1GM BASE/VIAL N62365 001 Aug 25, 1982 Feb CRLD
>A> + EQ 1GM BASE/VIAL N62365 001 Aug 25, 1982 Feb CRLD
>D> CHLOROMYCETIN
>D> AP + PARKEDALE EQ 1GM BASE/VIAL N50155 001 Feb DISC
>A> @ EQ 1GM BASE/VIAL N50155 001 Feb DISC
CHLOROTHIAZIDE
SUSPENSION; ORAL
DIURIL
>D> + MERCK 250MG/5ML N11870 001 Feb CAHN
>A> + SALIX PHARMS 250MG/5ML N11870 001 Feb CAHN
CITALOPRAM HYDROBROMIDE
>A> CAPSULE; ORAL
>A> CITALOPRAM HYDROBROMIDE
>A> ALPHAPHARM EQ 10MG BASE N77668 001 Feb 28, 2007 Feb NEWA
>A> EQ 20MG BASE N77668 002 Feb 28, 2007 Feb NEWA
>A> + EQ 40MG BASE N77668 003 Feb 28, 2007 Feb NEWA
CLOBETASOL PROPIONATE
SOLUTION; TOPICAL
CLOBETASOL PROPIONATE
>D> @ ALTANA 0.05% N75391 001 Feb 08, 1999 Feb CMFD
>A> AT 0.05% N75391 001 Feb 08, 1999 Feb CMFD
CLONIDINE HYDROCHLORIDE
TABLET; ORAL
CLONIDINE HYDROCHLORIDE
>A> AB VINTAGE 0.1MG N77901 001 Mar 09, 2007 Feb NEWA
>A> AB 0.2MG N77901 002 Mar 09, 2007 Feb NEWA
>A> AB 0.3MG N77901 003 Mar 09, 2007 Feb NEWA
CYCLOBENZAPRINE HYDROCHLORIDE
>A> CAPSULE, EXTENDED RELEASE; ORAL
>A> AMRIX
>A> ECR 15MG N21777 001 Feb 01, 2007 Feb NEWA
>A> + 30MG N21777 002 Feb 01, 2007 Feb NEWA
TABLET; ORAL
CYCLOBENZAPRINE HYDROCHLORIDE
>A> AB VINTAGE PHARMS 5MG N77797 001 Feb 28, 2007 Feb NEWA
>A> AB 10MG N77797 002 Feb 28, 2007 Feb NEWA
DEXTROAMPHETAMINE SULFATE
TABLET; ORAL
>D> DEXEDRINE
>D> AA GLAXOSMITHKLINE 5MG N84935 001 Feb DISC
>A> @ 5MG N84935 001 Feb DISC
DIDANOSINE
FOR SOLUTION; ORAL
>A> DIDANOSINE
>A> AA AUROBINDO PHARMA 10MG/ML N78112 001 Mar 08, 2007 Feb NEWA
VIDEX
>D> + BRISTOL MYERS 10MG/ML N20156 001 Oct 09, 1991 Feb CFTG
>A> AA + 10MG/ML N20156 001 Oct 09, 1991 Feb CFTG
DIMYRISTOYL LECITHIN; PERFLEXANE
INJECTABLE; INTRAVENOUS
IMAGENT
>D> @ IMCOR PH 0.92MG/VIAL;0.092MG/VIAL N21191 001 May 31, 2002 Feb CAHN
>A> @ IMCOR PHARMS CO 0.92MG/VIAL;0.092MG/VIAL N21191 001 May 31, 2002 Feb CAHN
ESTRADIOL
TABLET; ORAL
ESTRADIOL
>A> @ HERITAGE PHARMS INC 0.5MG N40275 001 Dec 29, 1998 Feb CAHN
>A> @ 1MG N40275 002 Dec 29, 1998 Feb CAHN
>A> @ 2MG N40275 003 Dec 29, 1998 Feb CAHN
>D> @ RADIUS PHARMS 0.5MG N40275 001 Dec 29, 1998 Feb CAHN
>D> @ 1MG N40275 002 Dec 29, 1998 Feb CAHN
>D> @ 2MG N40275 003 Dec 29, 1998 Feb CAHN
FAMOTIDINE
FOR SUSPENSION; ORAL
PEPCID
>D> + MERCK 40MG/5ML N19527 001 Feb 02, 1987 Feb CAHN
>A> + SALIX PHARMS 40MG/5ML N19527 001 Feb 02, 1987 Feb CAHN
FENOLDOPAM MESYLATE
INJECTABLE; INJECTION
FENOLDOPAM MESYLATE
>A> AP SICOR PHARMS EQ 10MG BASE/ML N77826 001 Mar 07, 2007 Feb NEWA
FINASTERIDE
TABLET; ORAL
FINASTERIDE
>A> AB DR REDDYS LABS 5MG N76437 001 Feb 28, 2007 Feb NEWA
FLUPHENAZINE HYDROCHLORIDE
TABLET; ORAL
FLUPHENAZINE HYDROCHLORIDE
>D> AB MYLAN 10MG N89804 001 Aug 12, 1988 Feb CRLD
>A> AB + 10MG N89804 001 Aug 12, 1988 Feb CRLD
GABAPENTIN
TABLET; ORAL
GABAPENTIN
>D> AB IVAX PHARMS 800MG N76017 005 Apr 29, 2005 Feb CRLD
>A> AB + 800MG N76017 005 Apr 29, 2005 Feb CRLD
NEURONTIN
>D> AB + PFIZER PHARMS 800MG N20882 002 Oct 09, 1998 Feb CRLD
>A> AB 800MG N20882 002 Oct 09, 1998 Feb CRLD
HEPARIN SODIUM
INJECTABLE; INJECTION
HEPARIN SODIUM
>A> @ WATSON LABS 1,000 UNITS/ML N17064 002 Feb CAHN
>A> @ 2,500 UNITS/ML N17064 015 Feb CAHN
>A> @ 3,000 UNITS/ML N17064 016 Feb CAHN
>A> @ 4,000 UNITS/ML N17064 017 Feb CAHN
>A> @ 5,000 UNITS/ML N17064 003 Feb CAHN
>A> @ 6,000 UNITS/ML N17064 018 Feb CAHN
>A> @ 7,500 UNITS/ML N17064 019 Feb CAHN
>A> @ 10,000 UNITS/ML N17064 004 Feb CAHN
>A> @ 20,000 UNITS/ML N17064 005 Feb CAHN
>A> @ 40,000 UNITS/ML N17064 006 Feb CAHN
>D> @ WATSON PHARMS 1,000 UNITS/ML N17064 002 Feb CAHN
>D> @ 2,500 UNITS/ML N17064 015 Feb CAHN
>D> @ 3,000 UNITS/ML N17064 016 Feb CAHN
>D> @ 4,000 UNITS/ML N17064 017 Feb CAHN
>D> @ 5,000 UNITS/ML N17064 003 Feb CAHN
>D> @ 6,000 UNITS/ML N17064 018 Feb CAHN
>D> @ 7,500 UNITS/ML N17064 019 Feb CAHN
>D> @ 10,000 UNITS/ML N17064 004 Feb CAHN
>D> @ 20,000 UNITS/ML N17064 005 Feb CAHN
>D> @ 40,000 UNITS/ML N17064 006 Feb CAHN
HYDRALAZINE HYDROCHLORIDE
TABLET; ORAL
HYDRALAZINE HYDROCHLORIDE
>A> @ HERITAGE PHARMS INC 25MG N86243 001 Feb CAHN
>A> @ 50MG N86242 002 Feb CAHN
>D> @ RADIUS PHARMS 25MG N86243 001 Feb CAHN
>D> @ 50MG N86242 002 Feb CAHN
HYDROCHLOROTHIAZIDE
TABLET; ORAL
HYDROCHLOROTHIAZIDE
>A> AB ACTAVIS ELIZABETH 12.5MG N40707 001 Feb 27, 2007 Feb NEWA
>A> AB HERITAGE PHARMS INC 25MG N85181 001 Feb CAHN
>A> AB 50MG N85182 001 Feb CAHN
>D> AB LEINER 25MG N85181 001 Feb CAHN
>D> AB 50MG N85182 001 Feb CAHN
>D> MYLAN 12.5MG N40770 001 Jan 23, 2007 Feb CTEC
>A> AB 12.5MG N40770 001 Jan 23, 2007 Feb CTEC
HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
TABLET; ORAL
>A> MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
>A> AB TEVA 12.5MG;7.5MG N76980 001 Mar 07, 2007 Feb NEWA
>A> AB 12.5MG;15MG N76980 003 Mar 07, 2007 Feb NEWA
>A> AB 25MG;15MG N76980 002 Mar 07, 2007 Feb NEWA
UNIRETIC
>D> SCHWARZ PHARMA 12.5MG;7.5MG N20729 001 Jun 27, 1997 Feb CFTG
>A> AB 12.5MG;7.5MG N20729 001 Jun 27, 1997 Feb CFTG
>D> 12.5MG;15MG N20729 003 Feb 14, 2002 Feb CFTG
>A> AB 12.5MG;15MG N20729 003 Feb 14, 2002 Feb CFTG
>D> + 25MG;15MG N20729 002 Jun 27, 1997 Feb CFTG
>A> AB + 25MG;15MG N20729 002 Jun 27, 1997 Feb CFTG
HYDROCORTISONE
TABLET; ORAL
CORTEF
>D> @ PHARMACIA AND 10MG N08697 001 Feb CMFD
>A> 10MG N08697 001 Feb CMFD
HYDROMORPHONE HYDROCHLORIDE
INJECTABLE; INJECTION
HYDROMORPHONE HYDROCHLORIDE
>D> AP WATSON LABS 10MG/ML N74317 001 Aug 23, 1995 Feb DISC
>A> @ 10MG/ML N74317 001 Aug 23, 1995 Feb DISC
HYDROXYZINE HYDROCHLORIDE
INJECTABLE; INJECTION
HYDROXYZINE HYDROCHLORIDE
>D> AP HOSPIRA 25MG/ML N87416 001 Feb DISC
>A> @ 25MG/ML N87416 001 Feb DISC
>D> AP 50MG/ML N87546 001 Feb DISC
>A> @ 50MG/ML N87546 001 Feb DISC
>D> AP WATSON LABS 50MG/ML N85779 001 Feb DISC
>A> @ 50MG/ML N85779 001 Feb DISC
ILOPROST
SOLUTION; INHALATION
VENTAVIS
>D> + ACTELION 10UGM/ML (10UGM/ML) N21779 002 Dec 08, 2005 Feb CAHN
>D> + 20UGM/2ML (10UGM/ML) N21779 001 Dec 29, 2004 Feb CAHN
>A> + ACTELION PHARM 10UGM/ML (10UGM/ML) N21779 002 Dec 08, 2005 Feb CAHN
>A> + 20UGM/2ML (10UGM/ML) N21779 001 Dec 29, 2004 Feb CAHN
INDOMETHACIN
CAPSULE; ORAL
INDOMETHACIN
>A> @ HERITAGE PHARMS INC 25MG N18851 001 May 18, 1984 Feb CAHN
>A> @ 50MG N18851 002 May 18, 1984 Feb CAHN
>D> MYLAN 25MG N18858 001 Apr 20, 1984 Feb CTEC
>A> AB 25MG N18858 001 Apr 20, 1984 Feb CTEC
>D> @ RADIUS PHARMS 25MG N18851 001 May 18, 1984 Feb CAHN
>D> @ 50MG N18851 002 May 18, 1984 Feb CAHN
>D> @ SANDOZ 25MG N70673 001 Apr 29, 1987 Feb CMFD
>A> AB 25MG N70673 001 Apr 29, 1987 Feb CMFD
>D> @ 50MG N70674 001 Apr 29, 1987 Feb CMFD
>A> AB 50MG N70674 001 Apr 29, 1987 Feb CMFD
IRON SUCROSE
INJECTABLE; INTRAVENOUS
VENOFER
>D> LUITPOLD EQ 50MG BASE/2.5ML(EQ 20MG BASE/ML) N21135 002 Mar 20, 2005 Feb DISC
>A> @ EQ 50MG BASE/2.5ML(EQ 20MG BASE/ML) N21135 002 Mar 20, 2005 Feb DISC
>D> EQ 75MG BASE/3.75ML(EQ 20MG N21135 003 Mar 29, 2005 Feb DISC
>A> @ EQ 75MG BASE/3.75ML(EQ 20MG N21135 003 Mar 29, 2005 Feb DISC
>A> EQ 200MG BASE/10ML(EQ 20MG N21135 004 Feb 09, 2007 Feb NEWA
KETOPROFEN
CAPSULE; ORAL
KETOPROFEN
>A> AB HERITAGE PHARMS INC 25MG N74014 001 Jan 29, 1993 Feb CAHN
>A> AB 50MG N74014 002 Jan 29, 1993 Feb CAHN
>A> AB 75MG N74014 003 Jan 29, 1993 Feb CAHN
>D> AB RADIUS PHARMS 25MG N74014 001 Jan 29, 1993 Feb CAHN
>D> AB 50MG N74014 002 Jan 29, 1993 Feb CAHN
>D> AB 75MG N74014 003 Jan 29, 1993 Feb CAHN
LIDOCAINE HYDROCHLORIDE
SOLUTION; ORAL
LIDOCAINE HYDROCHLORIDE VISCOUS
>A> AT VINTAGE 2% N40708 001 Feb 27, 2007 Feb NEWA
SOLUTION; TOPICAL
LIDOCAINE HYDROCLORIDE
>A> AT VINTAGE 4% N40710 001 Feb 27, 2007 Feb NEWA
>A> LISDEXAMFETAMINE DIMESYLATE
>A> CAPSULE; ORAL
>A> VYVANSE
>A> NEW RIVER 30MG N21977 001 Feb 23, 2007 Feb NEWA
>A> 50MG N21977 002 Feb 23, 2007 Feb NEWA
>A> + 70MG N21977 003 Feb 23, 2007 Feb NEWA
LOVASTATIN
TABLET, EXTENDED RELEASE; ORAL
ALTOPREV
>D> ANDRX LABS LLC 10MG N21316 001 Jun 26, 2002 Feb DISC
>A> @ 10MG N21316 001 Jun 26, 2002 Feb DISC
TABLET; ORAL
LOVASTATIN
>A> AB APOTEX INC 10MG N77748 001 Feb 28, 2007 Feb NEWA
>A> AB 20MG N77748 002 Feb 28, 2007 Feb NEWA
>A> AB 40MG N77748 003 Feb 28, 2007 Feb NEWA
METHYLPHENIDATE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
CONCERTA
>D> ALZA 18MG N21121 001 Aug 01, 2000 Feb CAHN
>D> 27MG N21121 004 Apr 01, 2002 Feb CAHN
>D> 36MG N21121 002 Aug 01, 2000 Feb CAHN
>D> + 54MG N21121 003 Dec 08, 2000 Feb CAHN
>A> JOHNSON AND 18MG N21121 001 Aug 01, 2000 Feb CAHN
>A> 27MG N21121 004 Apr 01, 2002 Feb CAHN
>A> 36MG N21121 002 Aug 01, 2000 Feb CAHN
>A> + 54MG N21121 003 Dec 08, 2000 Feb CAHN
METHYLPREDNISOLONE SODIUM SUCCINATE
INJECTABLE; INJECTION
METHYLPREDNISOLONE SODIUM SUCCINATE
>A> AP BEDFORD LABS EQ 40MG BASE/VIAL N40662 001 Feb 21, 2007 Feb NEWA
>A> AP EQ 125MG BASE/VIAL N40641 002 Feb 21, 2007 Feb NEWA
>A> AP EQ 500MG BASE/VIAL N40709 001 Feb 21, 2007 Feb NEWA
>A> AP EQ 500MG BASE/VIAL N40641 003 Feb 21, 2007 Feb NEWA
>A> AP EQ 1GM BASE/VIAL N40709 002 Feb 21, 2007 Feb NEWA
>A> AP EQ 1GM BASE/VIAL N40641 004 Feb 21, 2007 Feb NEWA
MIDAZOLAM HYDROCHLORIDE
INJECTABLE; INJECTION
>D> MIDAZOLAM HYDROCHLORIDE
>D> AP + HOSPIRA EQ 1MG BASE/ML N75857 001 Jul 22, 2002 Feb CTNA
>D> AP + EQ 5MG BASE/ML N75857 002 Jul 22, 2002 Feb CTNA
>A> AP TAYLOR EQ 1MG BASE/ML N75494 001 Jun 30, 2000 Feb CAHN
>A> AP EQ 5MG BASE/ML N75494 002 Jun 30, 2000 Feb CAHN
>D> AP TAYLOR PHARMA EQ 1MG BASE/ML N75494 001 Jun 30, 2000 Feb CAHN
>D> AP EQ 5MG BASE/ML N75494 002 Jun 30, 2000 Feb CAHN
>A> MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE
>A> AP + HOSPIRA EQ 1MG BASE/ML N75857 001 Jul 22, 2002 Feb CTNA
>A> AP + EQ 5MG BASE/ML N75857 002 Jul 22, 2002 Feb CTNA
MORPHINE SULFATE
CAPSULE, EXTENDED RELEASE; ORAL
KADIAN
>A> ALPHARMA US 200MG N20616 007 Feb 27, 2007 Feb NEWA
NALBUPHINE HYDROCHLORIDE
INJECTABLE; INJECTION
NALBUPHINE HYDROCHLORIDE
>D> AP HOSPIRA 10MG/ML N70915 001 Feb 03, 1989 Feb CRLD
>A> AP + 10MG/ML N70915 001 Feb 03, 1989 Feb CRLD
>D> AP 10MG/ML N70914 001 Feb 03, 1989 Feb CRLD
>A> AP + 10MG/ML N70914 001 Feb 03, 1989 Feb CRLD
>D> AP 20MG/ML N70918 001 Feb 03, 1989 Feb CRLD
>A> AP + 20MG/ML N70918 001 Feb 03, 1989 Feb CRLD
>D> AP 20MG/ML N70916 001 Feb 03, 1989 Feb CRLD
>A> AP + 20MG/ML N70916 001 Feb 03, 1989 Feb CRLD
>D> NUBAIN
>D> AP + ENDO PHARMS 10MG/ML N18024 001 Feb DISC
>A> @ 10MG/ML N18024 001 Feb DISC
>D> AP + 20MG/ML N18024 002 May 27, 1982 Feb DISC
>A> @ 20MG/ML N18024 002 May 27, 1982 Feb DISC
NESIRITIDE RECOMBINANT
FOR SOLUTION; INTRAVENOUS
NATRECOR
>D> + ALZA CORP 1.5MG/VIAL N20920 001 Aug 10, 2001 Feb CAHN
>A> + SCIOS 1.5MG/VIAL N20920 001 Aug 10, 2001 Feb CAHN
ONDANSETRON HYDROCHLORIDE
INJECTABLE; INJECTION
ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER
>A> AP MAYNE PHARMA USA EQ 0.64MG BASE/ML N76978 001 Feb 26, 2007 Feb NEWA
OXYCODONE HYDROCHLORIDE
TABLET; ORAL
ROXICODONE
>D> AB + XANODYNE PHARM 15MG N21011 001 Aug 31, 2000 Feb CAHN
>D> AB 30MG N21011 002 Aug 31, 2000 Feb CAHN
>A> AB + XANODYNE PHARMS 15MG N21011 001 Aug 31, 2000 Feb CAHN
>A> AB 30MG N21011 002 Aug 31, 2000 Feb CAHN
PAROXETINE HYDROCHLORIDE
TABLET; ORAL
PAROXETINE HYDROCHLORIDE
>A> AB ZYDUS PHARMS USA EQ 10MG BASE N77584 001 Mar 07, 2007 Feb NEWA
>A> AB EQ 20MG BASE N77584 002 Mar 07, 2007 Feb NEWA
>A> AB EQ 30MG BASE N77584 003 Mar 07, 2007 Feb NEWA
>A> AB EQ 40MG BASE N77584 004 Mar 07, 2007 Feb NEWA
PENTOXIFYLLINE
TABLET, EXTENDED RELEASE; ORAL
PENTOXIFYLLINE
>A> AB HERITAGE PHARMS INC 400MG N74877 001 Jul 08, 1997 Feb CAHN
>D> AB RADIUS PHARMS 400MG N74877 001 Jul 08, 1997 Feb CAHN
PHENTERMINE HYDROCHLORIDE
CAPSULE; ORAL
PHENTERMINE HYDROCHLORIDE
>D> AA AMBI PHARMS 30MG N40083 001 Mar 07, 1997 Feb CAHN
>D> AA SANDOZ 30MG N87190 001 Feb CRLD
>A> AA + 30MG N87190 001 Feb CRLD
>A> AA TG UNITED INC 30MG N40083 001 Mar 07, 1997 Feb CAHN
PILOCARPINE HYDROCHLORIDE
TABLET; ORAL
PILOCARPINE HYDROCHLORIDE
>A> AB ROXANE 7.5MG N76963 002 Feb 27, 2007 Feb NEWA
PIPERACILLIN SODIUM
INJECTABLE; INJECTION
PIPERACILLIN
>D> + ABRAXIS PHARM EQ 2GM BASE/VIAL N65114 001 Nov 14, 2003 Feb CAHN
>D> + EQ 3GM BASE/VIAL N65114 002 Nov 14, 2003 Feb CAHN
>D> + EQ 4GM BASE/VIAL N65114 003 Nov 14, 2003 Feb CAHN
>D> + EQ 40GM BASE/VIAL N65157 001 Jul 12, 2004 Feb CAHN
>A> + ISTITUTO BIOCHIMICO EQ 2GM BASE/VIAL N65114 001 Nov 14, 2003 Feb CAHN
>A> + EQ 3GM BASE/VIAL N65114 002 Nov 14, 2003 Feb CAHN
>A> + EQ 4GM BASE/VIAL N65114 003 Nov 14, 2003 Feb CAHN
>A> + EQ 40GM BASE/VIAL N65157 001 Jul 12, 2004 Feb CAHN
PREDNICARBATE
OINTMENT; TOPICAL
DERMATOP
>D> + SANOFI AVENTIS US 0.1% N19568 001 Sep 23, 1991 Feb CFTG
>A> AB + 0.1% N19568 001 Sep 23, 1991 Feb CFTG
>A> PREDNICARBATE
>A> AB ALTANA 0.1% N77236 001 Mar 09, 2007 Feb NEWA
PROCHLORPERAZINE
SUPPOSITORY; RECTAL
>D> COMPAZINE
>D> AB + GLAXOSMITHKLINE 25MG N11127 002 Feb DISC
>A> @ 25MG N11127 002 Feb DISC
PROCHLORPERAZINE
>D> AB G AND W LABS 25MG N40058 001 Nov 24, 1993 Feb CRLD
>A> AB + 25MG N40058 001 Nov 24, 1993 Feb CRLD
PROCHLORPERAZINE EDISYLATE
INJECTABLE; INJECTION
>D> COMPAZINE
>D> AP + GLAXOSMITHKLINE EQ 5MG BASE/ML N10742 002 Feb DISC
>A> @ EQ 5MG BASE/ML N10742 002 Feb DISC
>D> PROCHLORPERAZINE
>D> AP BAXTER HLTHCARE EQ 5MG BASE/ML N87759 001 Oct 01, 1982 Feb DISC
>A> @ EQ 5MG BASE/ML N87759 001 Oct 01, 1982 Feb DISC
PROCHLORPERAZINE EDISYLATE
>D> AP BAXTER HLTHCARE EQ 5MG BASE/ML N89903 001 Aug 29, 1989 Feb CRLD
>A> AP + EQ 5MG BASE/ML N89903 001 Aug 29, 1989 Feb CRLD
>D> AP HOSPIRA EQ 5MG BASE/ML N89703 001 Apr 07, 1988 Feb DISC
>A> @ EQ 5MG BASE/ML N89703 001 Apr 07, 1988 Feb DISC
>D> AP WATSON LABS EQ 5MG BASE/ML N89530 001 Jul 08, 1987 Feb DISC
>A> @ EQ 5MG BASE/ML N89530 001 Jul 08, 1987 Feb DISC
PROCHLORPERAZINE MALEATE
TABLET; ORAL
>D> COMPAZINE
>D> AB GLAXOSMITHKLINE EQ 5MG BASE N10571 001 Feb DISC
>A> @ EQ 5MG BASE N10571 001 Feb DISC
>D> AB EQ 10MG BASE N10571 002 Feb DISC
>A> @ EQ 10MG BASE N10571 002 Feb DISC
>D> AB + EQ 25MG BASE N10571 003 Feb DISC
>A> @ EQ 25MG BASE N10571 003 Feb DISC
PROCHLORPERAZINE MALEATE
>D> AB SANDOZ EQ 10MG BASE N40101 002 Jul 19, 1996 Feb CRLD
>A> AB + EQ 10MG BASE N40101 002 Jul 19, 1996 Feb CRLD
>D> AB EQ 25MG BASE N40101 003 Jul 19, 1996 Feb DISC
>A> @ EQ 25MG BASE N40101 003 Jul 19, 1996 Feb DISC
PROPOXYPHENE HYDROCHLORIDE
CAPSULE; ORAL
DOLENE
>A> @ HERITAGE PHARMS INC 65MG N80530 001 Feb CAHN
>D> @ RADIUS PHARMS 65MG N80530 001 Feb CAHN
PROPRANOLOL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
PROPRANOLOL HYDROCHLORIDE
>A> AB MYLAN 60MG N78022 001 Feb 15, 2007 Feb NEWA
>A> AB 80MG N78022 002 Feb 15, 2007 Feb NEWA
>A> AB 120MG N78022 003 Feb 15, 2007 Feb NEWA
>A> AB 160MG N78022 004 Feb 15, 2007 Feb NEWA
RABEPRAZOLE SODIUM
TABLET, DELAYED RELEASE; ORAL
ACIPHEX
>D> + EISAI MEDCL RES 20MG N20973 002 Aug 19, 1999 Feb CFTG
>A> AB + 20MG N20973 002 Aug 19, 1999 Feb CFTG
>A> RABEPRAZOLE SODIUM
>A> AB TEVA 20MG N76822 001 Feb 21, 2007 Feb NEWA
RAMIPRIL
>A> TABLET; ORAL
>A> ALTACE
>A> COBALT 1.25MG N22021 001 Feb 27, 2007 Feb NEWA
>A> 2.5MG N22021 002 Feb 27, 2007 Feb NEWA
>A> 5MG N22021 003 Feb 27, 2007 Feb NEWA
>A> + 10MG N22021 004 Feb 27, 2007 Feb NEWA
RANITIDINE HYDROCHLORIDE
SYRUP; ORAL
>A> RANITIDINE HYDROCHLORIDE
>A> AA ALPHARMA US EQ 15MG BASE/ML N76124 001 Feb 21, 2007 Feb NEWA
ZANTAC
>D> + GLAXOSMITHKLINE EQ 15MG BASE/ML N19675 001 Dec 30, 1988 Feb CFTG
>A> AA + EQ 15MG BASE/ML N19675 001 Dec 30, 1988 Feb CFTG
SERMORELIN ACETATE
INJECTABLE; INJECTION
GEREF
>A> + EMD SERONO EQ 0.05MG BASE/AMP N19863 001 Dec 28, 1990 Feb CAHN
>A> @ EQ 0.5MG BASE/VIAL N20443 001 Sep 26, 1997 Feb CAHN
>A> @ EQ 1MG BASE/VIAL N20443 002 Sep 26, 1997 Feb CAHN
>D> + SERONO EQ 0.05MG BASE/AMP N19863 001 Dec 28, 1990 Feb CAHN
>D> @ EQ 0.5MG BASE/VIAL N20443 001 Sep 26, 1997 Feb CAHN
>D> @ EQ 1MG BASE/VIAL N20443 002 Sep 26, 1997 Feb CAHN
SERTRALINE HYDROCHLORIDE
CONCENTRATE; ORAL
SERTRALINE HYDROCHLORIDE
>D> AB RANBAXY EQ 20MG BASE/ML N78053 001 Feb 05, 2007 Feb CTEC
>A> AA EQ 20MG BASE/ML N78053 001 Feb 05, 2007 Feb CTEC
>D> AB ROXANE EQ 20MG BASE/ML N76934 001 Jun 30, 2006 Feb CTEC
>A> AA EQ 20MG BASE/ML N76934 001 Jun 30, 2006 Feb CTEC
ZOLOFT
>D> AB + PFIZER EQ 20MG BASE/ML N20990 001 Dec 07, 1999 Feb CTEC
>A> AA + EQ 20MG BASE/ML N20990 001 Dec 07, 1999 Feb CTEC
SODIUM LACTATE
INJECTABLE; INJECTION
SODIUM LACTATE IN PLASTIC CONTAINER
>D> HOSPIRA 5MEQ/ML N18947 001 Sep 05, 1984 Feb CRLD
>A> + 5MEQ/ML N18947 001 Sep 05, 1984 Feb CRLD
SOMATROPIN RECOMBINANT
INJECTABLE; INJECTION
SAIZEN
>A> BX EMD SERONO 4MG/VIAL N19764 005 Jan 16, 2007 Feb CAHN
>A> BX 5MG/VIAL N19764 002 Oct 08, 1996 Feb CAHN
>A> @ 6MG/VIAL N19764 001 Oct 08, 1996 Feb CAHN
>A> + 8.8MG/VIAL N19764 003 Aug 29, 2000 Feb CAHN
>D> BX SERONO 4MG/VIAL N19764 005 Jan 16, 2007 Feb CAHN
>D> BX 5MG/VIAL N19764 002 Oct 08, 1996 Feb CAHN
>D> @ 6MG/VIAL N19764 001 Oct 08, 1996 Feb CAHN
>D> + 8.8MG/VIAL N19764 003 Aug 29, 2000 Feb CAHN
SEROSTIM
>A> BX EMD SERONO 4MG/VIAL N20604 003 Jul 25, 1997 Feb CAHN
>A> BX 5MG/VIAL N20604 002 Aug 23, 1996 Feb CAHN
>A> BX 6MG/VIAL N20604 001 Aug 23, 1996 Feb CAHN
>A> @ 8.8MG/VIAL N20604 004 Sep 06, 2001 Feb CAHN
>D> BX SERONO 4MG/VIAL N20604 003 Jul 25, 1997 Feb CAHN
>D> BX 5MG/VIAL N20604 002 Aug 23, 1996 Feb CAHN
>D> BX 6MG/VIAL N20604 001 Aug 23, 1996 Feb CAHN
>D> @ 8.8MG/VIAL N20604 004 Sep 06, 2001 Feb CAHN
INJECTABLE; SUBCUTANEOUS
SEROSTIM LQ
>A> @ EMD SERONO 6MG/0.5ML N20604 005 Feb 11, 2005 Feb CAHN
>D> @ SERONO 6MG/0.5ML N20604 005 Feb 11, 2005 Feb CAHN
SULFAMETHOXAZOLE; TRIMETHOPRIM
INJECTABLE; INJECTION
>D> BACTRIM
>D> AP + MUTUAL PHARM 80MG/ML;16MG/ML N18374 001 Feb DISC
>A> @ 80MG/ML;16MG/ML N18374 001 Feb DISC
SUSPENSION; ORAL
>D> BACTRIM PEDIATRIC
>D> AB MUTUAL PHARM 200MG/5ML;40MG/5ML N17560 002 Feb DISC
>A> @ 200MG/5ML;40MG/5ML N17560 002 Feb DISC
>D> SEPTRA
>D> AB + MONARCH PHARMS 200MG/5ML;40MG/5ML N17598 001 Feb DISC
>A> @ 200MG/5ML;40MG/5ML N17598 001 Feb DISC
>D> SEPTRA GRAPE
>D> AB MONARCH PHARMS 200MG/5ML;40MG/5ML N17598 002 Feb 12, 1986 Feb DISC
>A> @ 200MG/5ML;40MG/5ML N17598 002 Feb 12, 1986 Feb DISC
SULFAMETHOXAZOLE AND TRIMETHOPRIM
>D> AB TEVA 200MG/5ML;40MG/5ML N18812 001 Jan 28, 1983 Feb DISC
>A> @ 200MG/5ML;40MG/5ML N18812 001 Jan 28, 1983 Feb DISC
>D> AB 200MG/5ML;40MG/5ML N18812 002 Jun 10, 1983 Feb DISC
>A> @ 200MG/5ML;40MG/5ML N18812 002 Jun 10, 1983 Feb DISC
>D> AB TEVA PHARMS 200MG/5ML;40MG/5ML N77612 001 Nov 13, 2006 Feb CRLD
>A> AB + 200MG/5ML;40MG/5ML N77612 001 Nov 13, 2006 Feb CRLD
SULFASALAZINE
TABLET; ORAL
SULFASALAZINE
>A> @ HERITAGE PHARMS INC 500MG N80197 001 Feb CAHN
>D> @ RADIUS PHARMS 500MG N80197 001 Feb CAHN
SULINDAC
TABLET; ORAL
SULINDAC
>A> @ HERITAGE PHARMS INC 150MG N73262 002 Sep 06, 1991 Feb CAHN
>A> @ 200MG N73262 001 Sep 06, 1991 Feb CAHN
>D> @ RADIUS PHARMS 150MG N73262 002 Sep 06, 1991 Feb CAHN
>D> @ 200MG N73262 001 Sep 06, 1991 Feb CAHN
TERCONAZOLE
SUPPOSITORY; VAGINAL
TERCONAZOLE
>A> AB TARO 80MG N77553 001 Mar 09, 2007 Feb NEWA
THEOPHYLLINE
TABLET, EXTENDED RELEASE; ORAL
>D> QUIBRON-T/SR
>D> BC MONARCH PHARMS 300MG N87563 001 Jun 21, 1983 Feb DISC
>A> @ 300MG N87563 001 Jun 21, 1983 Feb DISC
TABLET; ORAL
>D> QUIBRON-T
>D> + MONARCH PHARMS 300MG N88656 001 Aug 22, 1985 Feb DISC
>A> @ 300MG N88656 001 Aug 22, 1985 Feb DISC
TRAMADOL HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
>D> TRAMADOL HYDROCHLORIDE
>D> BIOVAIL LABS INTL 100MG N21692 001 Sep 08, 2005 Feb CTNA
>D> 200MG N21692 002 Sep 08, 2005 Feb CTNA
>D> + 300MG N21692 003 Sep 08, 2005 Feb CTNA
>A> ULTRAM ER
>A> BIOVAIL LABS INTL 100MG N21692 001 Sep 08, 2005 Feb CTNA
>A> 200MG N21692 002 Sep 08, 2005 Feb CTNA
>A> + 300MG N21692 003 Sep 08, 2005 Feb CTNA
VERAPAMIL HYDROCHLORIDE
INJECTABLE; INJECTION
>D> ISOPTIN
>D> AP + FSC 2.5MG/ML N18485 001 Feb DISC
>A> @ 2.5MG/ML N18485 001 Feb DISC
VERAPAMIL HYDROCHLORIDE
>D> AP LUITPOLD 2.5MG/ML N70617 001 Nov 12, 1985 Feb CRLD
>A> AP + 2.5MG/ML N70617 001 Nov 12, 1985 Feb CRLD
>D> AP 2.5MG/ML N70225 001 Nov 12, 1985 Feb DISC
>A> @ 2.5MG/ML N70225 001 Nov 12, 1985 Feb DISC
TABLET; ORAL
CALAN
>D> AB GD SEARLE LLC 120MG N18817 002 Sep 10, 1984 Feb CRLD
>A> AB + 120MG N18817 002 Sep 10, 1984 Feb CRLD
>D> ISOPTIN
>D> AB FSC 40MG N18593 003 Nov 23, 1987 Feb DISC
>A> @ 40MG N18593 003 Nov 23, 1987 Feb DISC
>D> AB 80MG N18593 001 Mar 08, 1982 Feb DISC
>A> @ 80MG N18593 001 Mar 08, 1982 Feb DISC
>D> AB + 120MG N18593 002 Mar 08, 1982 Feb DISC
>A> @ 120MG N18593 002 Mar 08, 1982 Feb DISC
VERAPAMIL HYDROCHLORIDE
>A> @ HERITAGE PHARMS INC 80MG N71880 001 Apr 05, 1988 Feb CAHN
>A> @ 120MG N71881 001 Apr 05, 1988 Feb CAHN
>D> @ RADIUS PHARMS 80MG N71880 001 Apr 05, 1988 Feb CAHN
>D> @ 120MG N71881 001 Apr 05, 1988 Feb CAHN
ZONISAMIDE
CAPSULE; ORAL
ZONISAMIDE
>A> AB COREPHARMA 25MG N77876 001 Feb 21, 2007 Feb NEWA
>A> AB 50MG N77876 002 Feb 21, 2007 Feb NEWA
>A> AB 100MG N77876 003 Feb 21, 2007 Feb NEWA
ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL
SPONGE; TOPICAL
CHLORAPREP WITH TINT
>A> + ENTURIA INC 2%;70% (3ML) N20832 007 Oct 10, 2006 Feb NEWA
DOXYLAMINE SUCCINATE
TABLET; ORAL
UNISOM
>A> + CHATTEM 25MG N18066 001 Feb CAHN
>D> + MCNEIL CONS 25MG N18066 001 Feb CAHN
NONOXYNOL-9
SPONGE; VAGINAL
TODAY
>D> @ ALLENDALE PHARMS 1GM N18683 001 Apr 01, 1983 Feb CMFD
>A> + 1GM N18683 001 Apr 01, 1983 Feb CMFD
ORLISTAT
CAPSULE; ORAL
>A> ALLI
>A> + GLAXOSMITHKLINE 60MG N21887 001 Feb 07, 2007 Feb NEWA
RANITIDINE HYDROCHLORIDE
TABLET, EFFERVESCENT; ORAL
ZANTAC 75
>A> @ BOEHRINGER EQ 75MG BASE N20745 001 Feb 26, 1998 Feb CAHN
>D> @ MCNEIL CONS EQ 75MG BASE N20745 001 Feb 26, 1998 Feb CAHN
Date created: March 15, 2007; updated August 8, 2007 |
|
|
||||||
 | ||||||
|
||||||